| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.02 |